PreventionGenetics announces integration with FDNA's deep learning platform Face2Gene
18 December 2017
PreventionGenetics has announced the integration of their genetic testing and interpretation services with FDNA’s Face2Gene suite of applications
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
